The bacterial plasma membrane is a key interface during pathogen-host interactions, and 19 membrane composition enhances resistance against host antimicrobial defenses. Branched chain 20 fatty acids (BCFAs) are the major plasma membrane component in the intracellular Gram-21 positive pathogen Listeria monocytogenes (Lm) and BCFA metabolism is essential for Lm 22 growth and virulence. BCFA synthesis requires branched chain amino acids (BCAAs), and the 23 BCAA Isoleucine (Ile) is a necessary substrate for the predominant membrane anteiso-BCFAs 24 (ai-BCFAs) as well as an environmental signal for virulence regulation in Lm. In this study, we 25 explored how two proteins that metabolize or sense Ile contribute to Lm growth, BCFA 26 metabolism, and virulence. The IlvE aminotransferase incorporates Ile into ai-BCFAs, while 27
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CodY is an Ile-sensing regulator that coordinates BCAA synthesis and virulence gene 28 expression. Analysis of deletion mutants lacking IlvE (ilvE) or CodY (codY) revealed a major 29 role for IlvE under nutrient restriction and stress conditions. Cultures of the ilvE mutant 30 contained proportionally less ai-BCFAs relative to wild type, while of the codY mutant had a 31 lower proportion of ai-BCFAs in stationary phase, despite containing more cell-associated Ile. 32 Both ilvE and codY mutants required exogenous Ile for optimal growth, but the ilvE mutant 33 had an absolute requirement for Valine and Leucine when Ile was absent. IlvE was also 34 necessary for resistance to membrane stress, cell-to-cell spread, infection of primary 35 macrophages, and virulence in mice. Our findings implicate IlvE as an integral aspect of Lm 36 stress resistance and emphasize the central importance of Ile in Lm growth and virulence. Isoleucine (Ile) is an essential metabolite for protein translation and for synthesis of the 95 high ai-BCFA membrane content of Lm (Fig. 1A) , and the aminotransferase IlvE is predicted to 96 be the first enzyme that commits Ile into the biosynthetic pathway for odd-numbered (C15, C17) 97 ai-BCFAs. Low availability of Ile in the intracellular environment during infection is thought to 98 act as a signal for Lm to coordinate metabolism and virulence, mainly through the Ile-sensing 99 transcriptional regulator CodY (21, 26, 27) . To characterize dynamics of Ile usage in BCFA 100 biosynthesis and virulence, we assessed deletion mutant strains lacking IlvE or CodY (ilvE and 101 codY mutants) (Table S1 and Methods). 102 BCAA synthesis when these important metabolites are at low levels (31, 32) . We initially 141 hypothesized that bacteria lacking CodY would constitutively synthesize BCAAs in addition to 142 acquiring exogenous BCAAs, and therefore should be well positioned to generate sufficient 143 levels of ai-BCFAs regardless of growth phase. However, the observation that the codY mutant 144 had lower levels of ai-BCFAs in stationary phase in LDM (Fig. 1C ) prompted us to directly 145 measure levels of cell-associated BCAAs during growth in LDM. We therefore grew WT, 146 codY, ilvE and ilvE::ilvE + strains in LDM to mid-logarithmic and stationary phase, removed 147 the extracellular medium, and assessed cell-associated BCAA content by mass spectrometry 148 ( Fig. 1D-E) . Unsurprisingly, codY lysates contained higher levels of all three BCAAs relative 149 to WT during logarithmic growth, with Ile being the highest (~2.5-fold higher relative to WT), 150 confirming the role of CodY for BCAA synthesis during nutrient-restriction. Notably, we 151 observed approximately three-fold more Ile in stationary phase cultures for the codY mutant 152 relative to WT, but similar levels of Leu and Val. Thus, although the codY strain in stationary 153 8 phase contains more Ile available for ai-BCFA compared to WT, this strain does not match WT 154 levels of Ile incorporation into ai-BCFAs. These data suggest that CodY may play a role in 155 membrane ai-BCFA homeostasis during stationary phase through an as yet undefined 156 mechanism. 157 Since bacteria lacking IlvE showed a severe reduction in ai-BCFA content in LDM, we 158 hypothesized that the ilvE mutant would harbor higher levels of cell-associated Ile during all 159 growth phases in LDM compared to WT due to the lack of incorporation of this amino acid into 160 ai-BCFAs. However, we observed similar levels of Ile in the ilvE mutant and in WT during 161 logarithmic growth, and wide variability of cell-associated Ile in the ilvE strain during 162 stationary phase ( Fig. 1D -E). Also, Val was approximately half the level in the ilvE mutant 163 compared to WT in logarithmic and stationary phase ( Fig. 1D-E) , while the Leu level was less 164 than half of WT only in stationary phase. These data suggest that when IlvE is lacking, Lm uses 165
Val and Leu for BCFA metabolism. 166
167

Growth in BCAA-limiting conditions requires branched-chain aminotransferase IlvE 168
While fatty acid analysis represents relative levels of lipid species in a population of 169 cells, these data do not reveal differences in growth rate between strains. Therefore, we 170 examined the contributions of IlvE and CodY to bacterial growth in nutrient replete Brain-Heart 171 Infusion medium (BHI) and in nutrient-limited LDM. All growth experiments were initiated 172 using bacteria grown to mid-logarithmic phase in LDM. We hypothesized that because the 173 absence of CodY normally contributes to increased BCAA biosynthesis during Ile limitation 174 (26), codY bacteria would grow as well as, or better than, WT bacteria in LDM. We also 9 hypothesized that growth of the ilvE mutant would be slower than WT in nutrient-limited 176 medium due to its severe reduction in ai-BCFAs, a major membrane component for Lm. 177 In BHI, both the ilvE and the codY mutants grew equivalently to WT, showing that 178 IlvE and CodY are not essential for Lm growth in a nutrient rich environment ( Fig. 2A and Table  179 3). In LDM containing all three BCAAs at 100 g/mL, the ilvE strain grew slightly more 180 slowly than WT, whereas the codY strain grew the same as, or slightly better than, WT (Fig. 181 2B) . Although the ilvE culture reached the same maximum density as WT in LDM, its doubling 182 time during logarithmic growth was about 1.7-fold longer than WT (Table 3) . These data reveal 183 that ai-BCFA synthesis through IlvE contributes to bacterial growth rate when nutrients are 184 limited. In LDM, the ilvE::ilvE + complemented strain also grew more slowly than WT, despite 185 the fact that it was able to generate BCFA profiles similar to WT in this medium ( Fig. 1B-C) . We 186 therefore asked whether the ilvE gene is expressed at WT levels in the complemented strain. and Leu for synthesis of iso-BCFAs at higher levels than WT. Therefore, we asked how ilvE 191 and codY strains would grow when one or all three of the BCAAs are lacking in the growth 192 medium, despite having the ability to synthesize all three BCAAs de novo. In LDM lacking all 193 three BCAAs, all four strains grew poorly, with WT and ilvE::ilvE + reaching the highest 194 optical density at 600 nm (OD600) of ~0.4, compared to all strains reading ~0.6 in LDM when 195 all BCAAs were present ( Fig. 2B versus Fig. 3A) . Additionally, the ilvE mutant exhibited large 196 variability when no BCAAs were supplied, while codY grew the poorest (Fig. 2B versus Fig. 197 3A) . The fact that the codY mutant grew so poorly in medium with no exogenous BCAAs was 198 10 surprising considering that this mutant has no restriction on de novo synthesis of BCAAs. These 199 data support the semi-auxotrophic nature of Lm for BCAAs, highlighting the importance of 200 exogenous BCAAs for optimal growth and revealing a key role for IlvE and CodY when all 201 exogenous BCAAs are unavailable. 202
While IlvE is needed for enzymatic incorporation of Ile into BCFAs, CodY specifically 203 senses and binds cellular Ile (33, 34) . Due to their specific relationships with Ile, we then asked 204 how ilvE and codY mutants would grow when exogenous Ile is lacking but when Val and Leu 205 are present. Interestingly, both ilvE and codY strains were similarly attenuated when only Ile 206 was lacking, reaching a lower maximum density compared to WT and ilvE::ilvE + strains (Fig. 207 3B). Again, this was unexpected for the codY mutant, since we predicted that the codY strain 208 would have no growth defect in the absence of Ile due to its higher cell associated Ile 209 concentrations ( Fig. 1D-E) . These results reveal a complex role for CodY in Ile sensing and 210 BCAA homeostasis. We conclude that both IlvE and CodY are required for optimal bacterial 211 growth when exogenous Ile is absent. 212
When either all three BCAAs or only Ile were absent in the growth medium ( Fig. 3A-B ), 213 the ilvE and codY mutants were attenuated for growth to a similar degree. However, in media 214 containing exogenous Ile but lacking either of the other two BCAAs (Leu or Val), the two 215 mutants revealed unique growth phenotypes ( Fig. 3C-D) . In LDM containing Ile and one other 216 BCAA (Val or Leu), the codY mutant grew more robustly than WT, suggesting a dominant role 217 for Ile in Lm growth when CodY regulation is lacking. But the ilvE mutant showed strict 218 requirements for Leu and Val in the presence of Ile. When only Leu was absent (ie, Ile and Val 219 present), the ilvE mutant grew as it did in normal LDM (with all BCAAs, Fig. 2B ) for about 12 220 hours, but reached stationary phase early and then had a decrease in OD600 ( Fig. 3C ). When 221 11 only Val was absent (ie, Ile and Leu present), the ilvE strain was entirely unable to grow (Fig. 222 3D), revealing an absolute requirement for Val when exogenous Ile is not incorporated into ai-223
BCFAs by IlvE. The IlvE complemented strain was able to eventually reach a maximum density 224 in stationary phase similar to that of WT in all of these conditions ( Fig. 3A-D and in promoting optimal growth in BCAA-limited environments, we asked whether these 235 proteins specifically contribute to Lm pathogenesis. We hypothesized that the ilvE mutant 236 would be less efficient at intracellular growth in a cell culture infection model due to its 237 relatively slow growth during nutrient restriction. Previously, the codY mutant strain has shown 238 different behaviors in various in vitro macrophage infections models (25, 28). Since the codY 239 mutant in this study grew robustly in nutrient-limited LDM (Fig. 2B ), we predicted that it would 240 grow similarly to WT in primary macrophages. We also considered that the codY mutant would 241 be deficient in cell-to-cell spread given its stationary phase reduction of ai-BCFAs. 242
We infected primary bone marrow-derived murine macrophages (BMDM) with Lm 243 strains prepared from mid-log phase LDM cultures and measured viable intracellular bacteria at 244 0, 4 and 8 hours post infection. At 4 and 8 h post-infection, intracellular growth of the ilvE 245 mutant was at least 1 log lower than WT ( Fig. 4A ). However, the ilvE strain showed a growth 246 rate increase after 4 h, suggesting that this strain may be able to adapt to the intracellular 247 environment. The ilvE::ilvE + strain showed an intermediate phenotype, where intracellular 248 growth was less than that of WT but greater than that of the ilvE mutant. WT and codY strains 249 replicated within primary BMDM equivalently. We conclude that IlvE is required for optimal 250 growth in the nutrient-limited environment of macrophages, while CodY is not essential for 251 adaptation to intracellular growth within this cell type. 252
We then infected L929 cells with Lm strains prepared from mid-logarithmic LDM 253 cultures to assess the requirements for IlvE and CodY during multiple stages of intracellular 254 infection as measured by cell-to-cell spread ( Fig. 4B-C ). Plaques formed from infection with the 255 ilvE mutant were approximately 66% the size of WT-infected plaques (Fig. 4C ). The 256 complemented ilvE::ilvE + strain had a partially rescued plaque phenotype. We also observed 257 that plaques formed by the codY mutant were not significantly different from those of WT (Fig. 258 4C) . Taken together, these data demonstrate that IlvE is a critical component for Lm intracellular 259 growth and cell-to-cell spread. 260
261
IlvE enhances bacterial survival in response to exogenous membrane stress 262
Membrane BCFA content underlies Lm resistance to various cell stresses such as pH, 263 small molecules, low temperature, and host-specific antimicrobial mechanisms (8, 10, 12, 13, 16, 264 17, 35) . As a foodborne pathogen, Lm must survive the acidic stomach environment and resist 265 damage from host molecules such as bile. To investigate the role of Ile-dependent BCFA 266 metabolism in protecting Lm membrane integrity, we tested the ability of ilvE and codY 267 13 mutants to survive in the presence of membrane disrupting bile salts. We used a bile salt mixture 268 of cholic acid and deoxycholic acid, which are similar to the emulsifying bile acids in the 269 mammalian GI tract. We hypothesized that Lm lacking IlvE would be more susceptible to bile 270 salt stress than WT strains with a full complement of ai-BCFAs. Mid-logarithmic phase bacteria 271 grown in LDM were exposed to 0, 1, 2 and 4 mg/mL bile salts at 37C for 30 min and measured 272 by counting CFU (Fig. 5A ). WT Lm showed decreasing viability with increasing bile salt 273 concentration, with a reduction in viability of almost 2 logs from 0 to 4 mg/mL. The ilvE 274 mutant strain showed a consistent 1-log decrease in viability compared to WT at each 275 concentration. The complemented strain ilvE::ilvE + was slightly less viable at 1 mg/mL, but 276 was similar to WT at 2 and 4 mg/mL. Lastly, the codY mutant showed susceptibility to bile salt 277 stress similar to that of WT. We therefore conclude that IlvE promotes resilience against 278 membrane stress, likely through its role in populating the Lm membrane with ai-BCFAs. 279 280 IlvE is required for optimal infection of C57BL/6 mice 281
While in vitro infections can shed light on the intracellular growth capabilities of Lm, 282 they do not illuminate the more complex physiological dynamics of an animal infection. We 283 hypothesized that IlvE and CodY would contribute to pathogenesis in a mouse model of 284 infection, and that the IlvE would have more of an impact due to its constitutive role in 285 membrane fatty acid synthesis. We used a competitive index (CI) assay to measure the fitness of 286 Lm strains in C56BL/6 mice (36). Briefly, we injected mice intraperitoneally with a WT Lm 287 strain that is resistant to erythromycin (WT-erm r ) combined with a mutant strain (test strain-288 erm s ) in a 1:1 mixture (WT-erm r : test strain-erm s ). After 48 h, spleens and livers were removed 289 and bacteria plated on LB-agar with or without antibiotic to discern resistant (WT R ) versus 290 14 sensitive (test strain S ) bacteria and calculated the CI. The lower the CI, the less "competitive" the 291 test strain was compared to WT during infection. 292
In both spleen and liver ( Fig. 5B -C), substantially fewer ilvE bacteria were recovered. 293
The mean CI for the ilvE strain in both organs was less than 0.2, indicating severe attenuation 294 in mice. Although the IlvE complemented strain grew better in mice than the deletion mutant, it 295 was recovered at lower levels than WT, suggesting that robust expression of ilvE is necessary for 296 optimal survival in a whole animal. Lastly, while bacteria lacking CodY showed a CI of ~0.5 in 297 mouse spleen, a CI of 0.1 in liver suggests that the liver environment is a more restrictive growth 298 milieu for the codY mutant. Overall, these data underline a major role for ai-BCFA metabolism 299 Collectively, these findings suggest that within the nutrient-restricted intracellular environment, 350
Lm must be able to access sufficient Ile for ai-BCFA synthesis through IlvE activity, but must 351 also sense relative Ile limitation such that CodY metabolic inhibition is relieved to support 352 endogenous BCAA generation for optimal growth. 353
Another line of evidence pointing to the critical nature of IlvE in Lm biology is its major 354 role in supporting production of resilient membranes during nutrient restriction at biological 355 temperatures (37C). The importance of ai-BCFA membrane content for resistance to cold has 356 been well established for Lm, and indeed Lm is able to modulate the percentage of ai-BCFAs in 357 response to temperature, salinity, and pH (8, (15) (16) (17) . However, the Lm membrane is always 358 predominantly made up of Ile-primed odd-numbered ai-BCFAs, emphasizing the central 359 importance of the Ile-to-ai-BCFA biosynthetic pathway for this pathogen. Our demonstration 360 that bacteria lacking IlvE have greatly reduced ai-BCFA content and are sensitive to bile salts 361 directly implicates Ile usage by IlvE as a major player in synthesizing resilient bacterial 362 membranes. Within host cells, Lm is subjected to a variety of membrane-targeting host defenses 363 such as antimicrobial peptides, and ai-BCFAs have been shown to be important for resistance to 364 these mechanisms when the enzyme branched-chain -keto acid dehydrogenase (BKD), 365 downstream of IlvE, is lacking (13). While those stresses are experienced by Lm inside host 366 cells, Lm is a foodborne pathogen, and so must also survive the low pH of the stomach and the 367 high concentration of bile acids in the small intestine (37, 38). A lifestyle-specific evolution of 368 ai-BCFA metabolism is evident in the Gram-positive dental pathogen Streptococcus mutans, 369 which requires IlvE for acid tolerance, such as might be experienced in the oral cavity (39). 370
Thus, the contribution of IlvE for bile salt resistance in Lm reveals that a major need for Ile and 371 ai-BCFAs evolved as a fundamental physiological feature for surviving stress within the diverse 372 environments that this pathogen experiences. Further exploration into the mechanism of bile salt 373 resistance may reveal membrane structural features and bile salt transport mechanisms as playing 374 key roles. 375
The central importance for IlvE was also revealed by the severe attenuation of the ilvE 376 strain in cell culture and in a mouse model of listeriosis. As mentioned previously, the 377 intracellular milieu is nutrient-restricted and a site of antimicrobial assault. Thus, the decrease in 378 intracellular growth of Lm lacking IlvE after four hours of macrophage infection is likely due to 379 enhanced microbial killing, as was seen in the BKD mutant (13). However, it should be noted 380 that the ilvE mutant established growth macrophages between 4 and 8 hours, which may 381 indicate a regulatory stress response when Ile incorporation into ai-BCFAs is compromised. This 382 observation, combined with the fact that the ilvE mutant still had 20-30% ai-BCFAs during 383 growth in LDM, hints at the presence of another transaminase that can use Ile for ai-BCFA 384 synthesis. Different from what we observed, an Lm mutant lacking ilvE in a different parental 385 strain background was almost entirely lacking in ai-BCFAs when grown in rich medium, well 386 under 10% of fatty acid content (14), and this could mean that Lm has several regulatory 387 strategies for membrane homeostasis depending on the nutritional content of the growth medium. 388
However, the amount of ai-BCFAs that we observed in the absence of IlvE was not sufficient for 389 full virulence in a whole animal, highlighting the necessity of IlvE mediated ai-BCFA synthesis 390 for membranes during infection. 391
Lastly, our results also shed light on the complexity of CodY regulation, which in 392 addition to BCAA metabolism, is also known to be involved in nitrogen and carbon assimilation 393 and regulation of Lm virulence gene expression (21, 25, 27) . Previous studies of codY mutants 394 in in vitro macrophage models have shown different results, where CodY was not required for 395 growth in a transformed macrophage line (25), but was required for optimal growth within 396 primary macrophages (26). In our study, we did not observe a defect in growth within primary 397 macrophages for the codY mutant. But note that while the codY mutant had an identical fatty 398 acid profile to WT during logarithmic growth, it showed a significant reduction in ai-BCFAs 399 during stationary phase: and for our macrophage experiments, we used codY cultures that were 400 prepared at mid-logarithmic phase grown in nutrient-limited medium. This parameter may have 401 poised the bacteria to be more resistant to macrophage killing during the brief, 8-hour duration of 402 the experiment, and this possibility is currently being explored. Regardless, our data are the first 403 to describe a role for CodY in Lm pathogenesis in a whole animal model, where the codY 404 mutant was attenuated predominantly in the mouse liver. 405
In this study, we determined that the branched-chain amino acid transaminase IlvE plays 406 a central role in the membrane dynamics of L. monocytogenes and is necessary for robust 407 replication during intracellular infection in vitro and in vivo. Collectively, our findings highlight 408 an intricate connection between BCAA and BCFA metabolism, and further support a model 409
where Ile is a key metabolite for bacterial growth and virulence, in particular through the activity 410
CodY. Future investigation into how Lm remodels its membrane during interactions with the 411 host will expand our understanding of how pathogens use this defining cellular structure to 412 enhance infection. Listeria monocytogenes strains used in this study are listed in Supplemental Table S1 . 495
Wild Type (WT) L. monocytogenes is 10403S and all mutants indicated were created using this 496 parental background. Bacteria were grown in either BHI or LDM (29). Briefly, LDM contains 497 the following final concentrations: 50 mM MOPS/2 mM K 2 HPO 4 (pH 7.5), 0.02% 498 MgSO 4 *7H 2 O, 0.5 mM Ca(NO 3 ) 2 , 0.2% NH 4 Cl, 0.5% Glucose, 0.004% FeCl 3 /Na 3 -499 Citrate*2H 2 O, 0.5 g/mL Riboflavin, 1 g/mL Thiamine-HCl, 0.5g/mL Biotin, 0.005g/mL 500 Lipoic Acid, 100 g/mL of the amino acids Isoleucine, Leucine, Valine, Methionine, Arginine, 501
Histidine-HCl, Cysteine-HCl. Bone marrow derived murine macrophages (BMDM) were 502 isolated from wild type C57BL/6 mice per standard conditions and frozen in liquid nitrogen. The 503 day before in vitro infections, cells were thawed, spun by centrifugation, and resuspended in 504 The markerless, in-frame ilvE mutant was constructed using the pKSV7 recombination 511 plasmid (41) per standard conditions such that 1,020 base pairs of the coding sequence were 512 excised. The gene LMRG_02078 sequence in biocyc.org was used for mutant deletion method 513 design. The complemented strain ilvE::ilvE + was constructed using the ilvE parental strain by 514 26 inserting the coding sequence for LMRG_02078, including 500 base pairs upstream of the start 515 codon, using the shuttle integration vector pPL2 (42) per standard procedures. Note that two 516 independent complemented strains were constructed, one with a FLAG tag inserted at the 5 end 517 of the gene (ilvE::ilvE-FL). Primer sequences are listed in Supplementary Table S2 . 518
The codY null mutant was created by insertion-deletion of a spc gene originating from the 519 plasmid pJL73 (43). The entire codY coding sequence was replaced, in the same orientation, by 520 the spectinomycin resistance cassette using the shuttle vector pMAD (44) Cultures of all strains were grown in liquid LDM or BHI medium to Optical Density 600 527 nm (OD600) 0.40 -0.50 and frozen at -80C in 1 mL aliquots. Frozen stocks were titered for 528 viable bacteria, and on the day of experiments, aliquots were thawed at 37C for five minutes 529 and shaken at 37C in fresh medium for 30 minutes. Bacteria were then diluted 1:10 into fresh 530 medium and added to a Bioscreen C honeycomb 100-well plate in a 300 L volume in triplicate. 531
Plates were incubated at 37C for 24 hours with constant shaking at medium speed. OD600 532 readings were taken every 15 minutes on the Bioscreen C instrument. Growth was graphed in 533
Prism. Doubling times were calculated per (40) as follows: n = [log 10 (high OD 600 )log 10 (low 534 OD 600 )] / 0.3010 (where OD 600 values are from exponentially dividing cells). Doubling time = 535 time between OD600 / n. 536 27 Survival during exposure to Bile Salts was performed as follows. Strains were thawed 537 from frozen stocks of bacteria grown to mid-log (OD600 ~0.45) in LDM, added to fresh LDM, 538 and shaken at 37C for 30 min. Bacteria (~10 7 bacteria/mL) were then added to 4 mL of PBS 539 containing Bile Salts (Sigma #48305) at 0, 1, 2 and 4 mg/mL. Tubes were shaken at 37C for 30 540 min and then serially diluted with plating on LB-agar plates. 541 542
Fatty Acid Content 543
Bacteria were grown in LDM to mid-log (OD600 0.4-0.5) and stationary phase (OD600 544 0.9 -1.1), spun by centrifugation, washed 1X with PBS, spun again, and frozen at -20C. Cells 545 were sent on dry ice to Microbial ID for Whole Cell Fatty Acid Analysis. Experiments were 546 performed three times, independently. Results were combined and graphed in Prism 7 or 8 with 547 standard deviation. 548 549
Amino Acid Analysis 550
Strains grown on BHI agar were used to inoculate fresh liquid LDM and were grown to 551 mid-log (OD600 0.45 -0.55) or stationary phase (OD600 > 0.8). Cultures (12 or 10 mL) were 552 spun by centrifugation and washed one time with 2 mL 150 mM Ammonium Acetate. Cells were 553 again spun by centrifugation, the supernatant was removed, and cell pellets were snap frozen in a 554 dry ice-ethanol bath. Cells were stored at -80C until delivery to the Michigan Regional 555
Comprehensive Metabolomics Resource Core (MRC2) at the University of Michigan and 556 analyzed for total amino acid content as follows. Briefly, cells were homogenized in 200 L of 557 extraction solvent (20% water, 80% 1:1:1 methanol:acetonitrile:acetone) containing 13C or 15N-558 labeled amino acid internal standards. Samples were incubated at 4C for 10 min, vortexed, and 559 28 spun by centrifugation at 4C for 10 min at 14,000 rpm. Samples were diluted 20-fold and 560 transferred to autosampler vials for mass spectrometric analysis. Chromatographic separation of 561 underivatized amino acids was done using an Intrada Amino Acid column (Imtakt USA). Mobile 562 phases for separation were water:acetonitrile (8:2 v/v) containing 100 mM ammonium formate 563 (solvent A) and acetonitrile with 0.3% formic acid (solvent B). Flow rate was 0.6 ml/min, and 564 sample injection volume was 5 L. ESI-MS/MS data acquisition was performed in positive ion 565 mode on an Agilent 6410 LC-MS with MRM transitions programmed for both labeled and 566 unlabeled internal standards. A pooled plasma reference sample and "test pooled" sample were 567 included as quality controls. Calibration standards were prepared containing all 20 proteinogenic 568 amino acids at various concentrations and analyzed in replicate along with test samples. LC-MS 569 data were processed using MassHunter Quantitative Analysis software version B.07.00. Amino 570 acids were quantified as pmol/million cells (ascertained by serial dilution and plating) and as 571 pmol/g total protein using linear calibration curves generated form the standards listed above. 572
All peak areas in samples and calibration standards were first normalized to the peak area of the 573 internal standards. 574 575
In vitro bone marrow derived macrophage infections 576
Bone marrow derived macrophages (see Bacteria, cell culture and media) were thawed 577 and plated in 24-well tissue culture plates with 2.5 X 10 5 cells/well and allowed to recover 578 overnight (~18 hours) at 37C/5% CO 2 . Following recovery, medium was removed and replaced 579 with 500 L of DMEM (no antibiotics) containing bacteria (prepped as in Growth Curve 580 analysis) at Multiplicity of Infection (MOI) of one. BMDM with bacteria were incubated for 30 581 min at 37C/5% CO 2 and then washed three times with warm DPBS++ (+Calcium and 582 29 +Magnesium Chloride -Gibco 14040). One mL fresh DMEM-10 with Gentamicin (50 g/mL) 583 was added to cells to kill extracellular bacteria. Cells were incubated for 0, 4 and 8 hours. At 584 time of harvest, cells were washed one time with DPBS++ and then incubated in 1 mL of 0.1% 585 Triton-X for 5 min. Cells were removed by scraping and pipetting and then transferred to 3.5 586 mL sterile double distilled water and vortexed for 10s. 500 L 10X PBS was added to promote 587 bacterial integrity. Samples were either directly plated or serially diluted and then plated on LB-588 agar plates and incubated overnight at 37C. Experiments were done with three technical 589 replicates per experiment on three separate days. Data were compiled and graphed in Prism 7 or 590 8. 591
592
In vivo mouse experiments 593
Mouse experiments were performed with 6 to 7-week-old female BALB/c mice. Bacteria 594 were grown in BHI to OD600 0.50 and frozen in 1 mL aliquots. On the day of experiments, 595 bacteria were thawed and resuspended in 3 mL of fresh BHI and incubated with shaking for 1.5 596 hours at 37C. Bacteria were pelleted by centrifugation, washed one time with sterile PBS, 597 pelleted again, and then resuspended in 1 mL sterile PBS. Bacteria were serially diluted and 598 plated to ascertain original titer. Bacteria were then combined in the following strain 599 combinations in a 1:1 ratio to attain a concentration of 10 5 CFU of each strain per 100 L of 600 PBS. WT-erm r :WT-erm s ; WT-erm r :ilvE-erm s ; WT-erm r :ilvE::ilvE + -erm s ; WT-erm r :codY-601 erm s . Mice were injected peritoneally with 100 L of bacterial inoculum. Inocula for all strain 602 combinations were serially diluted and plated on LB-agar and LB-agar-erythromycin plates to 603 measure INPUT concentrations. Mice were then housed for 48 hours in biocontainment rooms 604 before sacrifice and harvest of spleens and livers. Spleens were homogenized in 1 mL sterile 605 (9) Log-phase bacteria grown in LDM were added to PBS with 0, 1, 2 and 4 mg/mL Bile Salts (Cholic acid-Deoxycholic acid sodium salt mixture) and incubated at 37°C for 30 minutes. Input for all samples was ~10 7 CFU/mL. Data are compiled from three independent experiments. One-way ANOVA (non-parametric) with Dunn's multiple comparisons post-test comparing mutant strains to WT. ns = not significant; *P<0.05; ***P<0.001; ****P<0.0001. (B and C) Female C56BL/6 mice were infected with a 1:1 mixture of erythromycin-sensitive test strains and erythromycin-resistant WT strain via intraperitoneal injection. After 48h infection, (B) spleens and (D) livers were harvested and assessed for viable CFU and competitive index (CI) was calculated as the ratio of Sensitive/Resistant CFU. Data represent two independent experiments with total n=7 mice for all strains except WT, which was n=8. LOD = limit of detection.
